Clinical trials: Radiodermatitis
Radiation Dermatitis
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care® Gel
The radiotherapy after surgery reduces the risk of recurrence and death is widely used for standard treatment for cancer including breast cancer and head and neck cancer.
- Trial name
- NCT04995328
- Testing
- Radiation Care Gel
- Where
- Taiwan
- Volunteers
- 23 people
- Sponsor
- China Medical University Hospital
Breast Carcinoma, Radiation-Induced Dermatitis
Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer
This randomized pilot clinical trial studies how well topical keratin works in treating radiation dermatitis in patients with breast cancer.
- Trial name
- NCT03374995
- Testing
- Best Practice, Quality-of-Life Assessment, Topical Keratin
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Wake Forest University Health Sciences
Head and Neck Carcinoma, Radiation-Induced Dermatitis
Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
This randomized phase 3 trial studies how well modified Dakin's solution works in reducing radiation-induced dermatitis, a common skin reaction to radiation therapy, in patients with head and neck cancer undergoing radiation…
- Trial name
- NCT02369835
- Testing
- Dakin's solution
- Where
- 2 sites in United States
- Volunteers
- 132 people
- Sponsor
- Stanford University
Radiodermatitis, Oncology
Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.
Testing the efficacy of the Jalosome® Soothing gel in 2 or 3 grade radiodermatitis healing in oncological patients. The investigators would like to know also the efficacy of the device on quality of life and pain.
- Conditions
- Radiodermatitis, Oncology, Quality of Life, Pain
- Trial name
- NCT04692389
- Testing
- Jalosome soothing gel
- Where
- Switzerland
- Sponsor
- Welcare Industries SpA
Breast Cancer, Radio Dermatitis
Photobiomodulation in Radiodermatitis in People With Breast Cancer
Most breast cancer patients undergoing radiotherapy develop radiodermatitis, making it one of the most prevalent adverse events during cancer treatment.
- Trial name
- NCT06990165
- Testing
- Photobiomodulation
- Where
- 2 sites in Brazil
- Volunteers
- 148 people
- Sponsor
- Instituto Nacional de Cancer, Brazil
Breast Cancer, Radiation Dermatitis
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
Breast cancer is the top one incidence of cancer in women. Whole breast radiation therapy plays an indispensable role in the course of breast cancer treatment, and the radiation dermatitis is the major side effect affected…
- Trial name
- NCT06040983
- Testing
- FR-101 Chest Dressing
- Volunteers
- 30 people
- Sponsor
- China Medical University Hospital
Radiation Dermatitis, Radiation Dermatitis Acute
Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer
The aim of the present randomized double-blinded placebo-controlled clinical trial is to investigate if melatonin can protect against acute radiation dermatitis in patients with early breast cancer receiving radiation therapy…
- Conditions
- Radiation Dermatitis, Radiation Dermatitis Acute, Breast Cancer
- Trial name
- MELADERM (NCT03716583)
- Testing
- Melatonin, Dimethyl Sulfoxide
- Where
- Denmark
- Volunteers
- 48 people
- Sponsor
- Dennis Bregner Zetner
Head and Neck Cancer, Pelvic Cancer
Health Oriented Protocol for Epidermal Radiodermatitis
Radiation therapy is a standard treatment for malignant tumors of the head and neck and pelvic regions, used alone or in combination with chemotherapy.
- Conditions
- Head and Neck Cancer, Pelvic Cancer, Radiation Skin Injury, Gynecologic Cancer
- Trial name
- HOPE (NCT07129525)
- Testing
- Radiation therapy
- Where
- Italy
- Volunteers
- 80 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Radiation Dermatitis
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
The aim of this study is to assess the efficacy and safety of StrataXRT® in comparison to standard of care (defined using the Common Terminology Criteria for Adverse Events [CTCAE], version 5.0) by assessing the severity of…
- Trial name
- NCT05553392
- Testing
- StrataXRT, Aquaphor
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Stratpharma AG
Prevention
Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
the purpose of this study is to evaluate the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
- Trial name
- NCT07256119
- Testing
- Alpha Lipoic Acid
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Ain Shams University
Radiodermatitis; Acute
Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients
This study aims to compare the prophylactic effect of topical betamethasone valerate cream and topical olive oil cream in the prevention of acute radiation dermatitis (ARD) in breast cancer patients treated with radiation.
- Trial name
- NCT05285943
- Testing
- Olive oil cream, Betamethasone Valerate Cream, Base Cream
- Where
- Egypt
- Volunteers
- 132 people
- Sponsor
- Cairo University
Radiodermatitis
Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis
Dose response curve to define the security and tolerable dose to be used for prevention and treatment of radiodermatitis in patients with breast or head and neck cancer.
- Trial name
- DRCPTR (NCT02249884)
- Testing
- Urea Dose A, Urea Dose B, Urea Dose C
- Where
- Brazil
- Volunteers
- 30 people
- Sponsor
- University of Brasilia
Breast Cancer
Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients
Ionizing radiation is a toxic agent and widely accepted form of treatment for various types of cancer. Despite advances in medical technology, radiation therapy still causes severe early and late skin effects.
- Trial name
- NCT01042938
- Testing
- Curcumin C3 Complex
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- University of Rochester
Radiodermatitis; Acute, Radiotherapy Side Effect
The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients
It is estimated that there will be 670,000 new cases of cancer worldwide in 2020-2022 and it is known that the most commonly instituted treatments in cancer are chemotherapy, radiotherapy and surgery.
- Conditions
- Radiodermatitis; Acute, Radiotherapy Side Effect, Head and Neck Cancer
- Trial name
- NCT05557825
- Testing
- Photobiomodulation Therapy
- Where
- Brazil
- Volunteers
- 3 people
- Sponsor
- University of Nove de Julho
Radiation Dermatitis
Clinical Trial of CSMed Wound Dressing for Radiation Dermatitis
Investigate the effects of CSMed® for preventing and managing radiation dermatitis in patients with Breast cancer and Head-Neck cancer receiving radiotherapy (≥50 Gy).
- Trial name
- NCT06001463
- Testing
- CSMed Dressing
- Where
- Taiwan
- Volunteers
- 30 people
- Sponsor
- Chung Shan Medical University
Radiodermatitis
Preventive Effect of Boron-based Gel on Radiation Dermatitis
Preventive Effect of Boron-based Gel on Radiation Dermatitis
- Trial name
- boron_gel (NCT04239560)
- Testing
- Boron-based Gel (Fibore)
- Where
- Iran
- Volunteers
- 257 people
- Sponsor
- Tabriz University of Medical Sciences
Radiation Dermatitis
ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer
Severe radiation dermatitis remains a challenging complication in head and neck cancer with limited treatment options; this study aims to evaluate a novel Prussian blue-based nanozyme combined with near-infrared thermotherapy to…
- Trial name
- NCT07086638
- Testing
- Photo-responsive nanozyme
- Where
- China
- Volunteers
- 5 people
- Sponsor
- West China Hospital
Radiodermatitis
Evaluation of Fenofibrate on Radiation-induced Skin Injury
Fenofibrate is a specific ligand for PPARα, which has been used for the treatment of hypercholesterolemia, hypertriglyceridemia, diabetes and cardiovascular diseases for long time.
- Trial name
- NCT03557983
- Testing
- Fenofibrate, Saline
- Where
- China
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Second Affiliated Hospital of Soochow University
Head and Neck Neoplasms, Radiodermatitis
Topical Boswellia Serrata 2% to Prevent Radiation Dermatitis in Head and Neck Cancer
This study evaluates a topical 2% Boswellia serrata (Indian olibanum) gum-resin cream for the prevention of acute radiation-induced dermatitis in patients with head and neck cancer undergoing radiotherapy.
- Trial name
- NCT07778290
- Testing
- Boswellia serrata 2% topical cream
- Where
- 2 sites in Egypt
- Volunteers
- 60 people
- Sponsor
- Youssef Hashem Hafez
Radiation Dermatitis
Efficacy of Superoxide Dismutase Spray in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .
Radiotherapy always results in many complications such as radiation dermatitis,dry mouth, cranial nerve damage, and swallowing function.
- Trial name
- NCT07400016
- Testing
- SOD spray
- Volunteers
- healthy volunteers welcome
- Sponsor
- West China Hospital